
Abbott
Price
Price
CHART BY
Historical dividends and forecast
Abbott has so far distributed $0.59 in 2025. The next dividend will be paid on 15.05.2025
CHART BY
Frequently asked questions
What is Abbott's market capitalization?
What is Abbott's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Abbott?
What are the analyst ratings and target price for Abbott's stock?
What is Abbott's revenue over the trailing twelve months?
Is Abbott paying dividends?
What is the EBITDA for Abbott?
What is the free cash flow of Abbott?
How many employees does Abbott have, and what sector and industry does it belong to?
What is the free float of Abbott's shares?
Financials
- Market Cap
- $230.06B
- EPS (TTM)
- $7.662
- Free Float
- 1.72B
- P/E ratio (TTM)
- 17.37
- Revenue (TTM)
- $41.95B
- EBITDA (TTM)
- $10.10B
- Free Cashflow (TTM)
- $6.35B
Pricing
- 1D span
- $131.05$135.24
- 52W span
- $99.71$141.01
Analyst Ratings
The price target is $138.14 and the stock is covered by 29 analysts.
Buy
19
Hold
9
Sell
1
Information
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
- Employees
- 114,000
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US0028241000
- Primary Ticker
- ABT